• Client Login
Ozmosi
  • Services
    • BEAM Clinical Trial Data
    • GCT Global Clinical Trials
    • PRYZM Pharma Product Database
    • KRYSTL Industry Scan Reporting
    • LENZ Company Pipeline Summary
    • Specialized Consulting
    • Approved Pharmaceutical Products in Use
  • About Us
  • Case Studies
  • Newsroom
  • Conference Info
  • Contact Us
Select Page
China Reshaping the Clinical Trial Pipeline

China Reshaping the Clinical Trial Pipeline

Jan 29, 2024 | Clinical Trial Trends, Global Trends

Finally, the data is in here at OZMOSI, and we can start tracking and reporting on the clinical development expected to come out of China.  Gone are the days of developing drugs only in the US and then watching them slowly make their way to the rest of the world....
Keeping up with the Pharmaceutical Industry in Asia

Keeping up with the Pharmaceutical Industry in Asia

Oct 27, 2023 | Clinical Trial Trends, Global Trends

Keeping up with the pharmaceutical landscape around the world, especially in Asia, is essential in today’s market. Here are some of the biggest news stories emerging from Asian countries that are making big strides in drug development. China: Recently, China has been...

Recent Posts

  • OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&DMay 13, 2026
  • Pharmaceutical Portfolio Strategy in the AI Era: Why External Intelligence MattersApril 29, 2026
  • Why AI Stalls in Pharmaceutical R&D Operations (and How to Fix It)March 31, 2026
  • Who is Winning in Innovation and How are They Balancing Risk?February 28, 2026
  • How Next-Generation Probability of Success Forecasting Can Improve Clinical Trial Accuracy by 44%January 16, 2026
  • Market Overview: GLP-1 Agonists and the Obesity MarketDecember 16, 2025
  • Home
  • About Us
  • Services
  • Case Studies
  • Newsroom
  • Contact Us
  • Facebook
  • X
OZMOSI© 2025 | All Rights Reserved | Site by Webtyde